Skip to main content
Top
Published in: Population Health Metrics 1/2017

Open Access 01-12-2017 | Research

Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks

Authors: Vincent Y. F. He, John R. Condon, Peter D. Baade, Xiaohua Zhang, Yuejen Zhao

Published in: Population Health Metrics | Issue 1/2017

Login to get access

Abstract

Background

Net survival is the most common measure of cancer prognosis and has been used to study differentials in cancer survival between ethnic or racial population subgroups. However, net survival ignores competing risks of deaths and so provides incomplete prognostic information for cancer patients, and when comparing survival between populations with different all-cause mortality. Another prognosis measure, “crude probability of death”, which takes competing risk of death into account, overcomes this limitation. Similar to net survival, it can be calculated using either life tables (using Cronin-Feuer method) or cause of death data (using Fine-Gray method). The aim of this study is two-fold: (1) to compare the multivariable results produced by different survival analysis methods; and (2) to compare the Cronin-Feuer with the Fine-Gray methods, in estimating the cancer and non-cancer death probability of both Indigenous and non-Indigenous cancer patients and the Indigenous cancer disparities.

Methods

Cancer survival was investigated for 9,595 people (18.5% Indigenous) diagnosed with cancer in the Northern Territory of Australia between 1991 and 2009. The Cox proportional hazard model along with Poisson and Fine-Gray regression were used in the multivariable analysis. The crude probabilities of cancer and non-cancer methods were estimated in two ways: first, using cause of death data with the Fine-Gray method, and second, using life tables with the Cronin-Feuer method.

Results

Multivariable regression using the relative survival, cause-specific survival, and competing risk analysis produced similar results. In the presence of competing risks, the Cronin-Feuer method produced similar results to Fine-Gray in the estimation of cancer death probability (higher Indigenous cancer death probabilities for all cancers) and non-cancer death probabilities (higher Indigenous non-cancer death probabilities for all cancers except lung cancer and head and neck cancers). Cronin-Feuer estimated much lower non-cancer death probabilities than Fine-Gray for non-Indigenous patients with head and neck cancers and lung cancers (both smoking-related cancers).

Conclusion

Despite the limitations of the Cronin-Feuer method, it is a reasonable alternative to the Fine-Gray method for assessing the Indigenous survival differential in the presence of competing risks when valid and reliable subgroup-specific life tables are available and cause of death data are unavailable or unreliable.
Appendix
Available only for authorised users
Literature
1.
go back to reference Condon J, Zhang X, Baade P, Griffiths K, Cunningham J, Roder D, Coory M, Jelfs P, Threlfall T. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul Health Metrics. 2014;12:1.CrossRef Condon J, Zhang X, Baade P, Griffiths K, Cunningham J, Roder D, Coory M, Jelfs P, Threlfall T. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality. Popul Health Metrics. 2014;12:1.CrossRef
2.
go back to reference Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples 2015. Cat. no. IHW 147. Canberra: AIHW; 2015. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples 2015. Cat. no. IHW 147. Canberra: AIHW; 2015.
3.
go back to reference Mariotto AB, Noone A-M, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM. Cancer survival: an overview of measures, uses, and interpretation. JNCI Monogr. 2014;2014:145–86.CrossRef Mariotto AB, Noone A-M, Howlader N, Cho H, Keel GE, Garshell J, Woloshin S, Schwartz LM. Cancer survival: an overview of measures, uses, and interpretation. JNCI Monogr. 2014;2014:145–86.CrossRef
4.
5.
go back to reference Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. JNCI Monogr. 2014;2014:255–64.CrossRef Howlader N, Mariotto AB, Woloshin S, Schwartz LM. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death. JNCI Monogr. 2014;2014:255–64.CrossRef
6.
go back to reference Withrow DR, Racey CS, Jamal S. A critical review of methods for assessing cancer survival disparities in indigenous population. Ann Epidemiol. 2016;26:579–91.CrossRefPubMed Withrow DR, Racey CS, Jamal S. A critical review of methods for assessing cancer survival disparities in indigenous population. Ann Epidemiol. 2016;26:579–91.CrossRefPubMed
7.
go back to reference Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584–98.CrossRefPubMedPubMedCentral Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584–98.CrossRefPubMedPubMedCentral
8.
go back to reference Baade PD, Dasgupta P, Dickman PW, Cramb S, Williamson JD, Condon JR, Garvey G. Quantifying the changes in survival inequality for Indigenous people diagnosed with cancer in Queensland, Australia. Cancer Epidemiol. 2016;43:1–8.CrossRefPubMed Baade PD, Dasgupta P, Dickman PW, Cramb S, Williamson JD, Condon JR, Garvey G. Quantifying the changes in survival inequality for Indigenous people diagnosed with cancer in Queensland, Australia. Cancer Epidemiol. 2016;43:1–8.CrossRefPubMed
9.
go back to reference Zakeri K, MacEwan I, Vazirnia A, Cohen EEW, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014;50:40–4.CrossRefPubMed Zakeri K, MacEwan I, Vazirnia A, Cohen EEW, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014;50:40–4.CrossRefPubMed
10.
go back to reference Eloranta S, Adolfsson J, Lambert PC, Stattin P, Akre O, Andersson TM, Dickman PW. How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden. Cancer Causes Control. 2013;24:505–15.CrossRefPubMed Eloranta S, Adolfsson J, Lambert PC, Stattin P, Akre O, Andersson TM, Dickman PW. How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden. Cancer Causes Control. 2013;24:505–15.CrossRefPubMed
11.
go back to reference Condon JR, Barnes T, Cunningham J, Smith L. Demographic characteristics and trends of the Northern Territory Indigenous population, 1966 to 2001. Darwin: Cooperative Research Centre for Aboriginal Health; 2004. Condon JR, Barnes T, Cunningham J, Smith L. Demographic characteristics and trends of the Northern Territory Indigenous population, 1966 to 2001. Darwin: Cooperative Research Centre for Aboriginal Health; 2004.
12.
go back to reference Condon J, Zhao Y, Armstrong B, Barnes T. Northern Territory Cancer Register data quality, 1981–2001. Darwin: NT Cancer Registry, the Cooperative Research Centre for Aboriginal Health, Charles Darwin University and the Menzies School of Health Research; 2004. Condon J, Zhao Y, Armstrong B, Barnes T. Northern Territory Cancer Register data quality, 1981–2001. Darwin: NT Cancer Registry, the Cooperative Research Centre for Aboriginal Health, Charles Darwin University and the Menzies School of Health Research; 2004.
14.
go back to reference Dickman PW, Coviello E, Hills M. Estimating and modelling relative survival. Stata J. 2009;15:186–215. Dickman PW, Coviello E, Hills M. Estimating and modelling relative survival. Stata J. 2009;15:186–215.
15.
go back to reference Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51–64.CrossRefPubMed Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51–64.CrossRefPubMed
16.
go back to reference Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000;19:1729–40.CrossRefPubMed Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000;19:1729–40.CrossRefPubMed
17.
go back to reference Eloranta S, Lambert PC, Andersson TM, Czene K, Hall P, Björkholm M, Dickman PW. Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models. BMC Med Res Methodol. 2012;12:1.CrossRef Eloranta S, Lambert PC, Andersson TM, Czene K, Hall P, Björkholm M, Dickman PW. Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models. BMC Med Res Methodol. 2012;12:1.CrossRef
18.
go back to reference Hinchliffe SR, Rutherford MJ, Crowther MJ, Nelson CP, Lambert PC. Should relative survival be used with lung cancer data? Br J Cancer. 2012;106:1854–9.CrossRefPubMedPubMedCentral Hinchliffe SR, Rutherford MJ, Crowther MJ, Nelson CP, Lambert PC. Should relative survival be used with lung cancer data? Br J Cancer. 2012;106:1854–9.CrossRefPubMedPubMedCentral
19.
go back to reference Blakely T, Soeberg M, Carter K, Costilla R, Atkinson J, Sarfati D. Bias in relative survival methods when using incorrect life‐tables: Lung and bladder cancer by smoking status and ethnicity in New Zealand. Int J Cancer. 2012;131:E974–82.CrossRefPubMed Blakely T, Soeberg M, Carter K, Costilla R, Atkinson J, Sarfati D. Bias in relative survival methods when using incorrect life‐tables: Lung and bladder cancer by smoking status and ethnicity in New Zealand. Int J Cancer. 2012;131:E974–82.CrossRefPubMed
20.
go back to reference Ellis L, Coleman M, Rachet B. The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer. Br J Cancer. 2014;111:195–202.CrossRefPubMedPubMedCentral Ellis L, Coleman M, Rachet B. The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer. Br J Cancer. 2014;111:195–202.CrossRefPubMedPubMedCentral
21.
go back to reference Baade PD, Turrell G, Aitken JF. A multilevel study of the determinants of area-level inequalities in colorectal cancer survival. BMC Cancer. 2010;10:24.CrossRefPubMedPubMedCentral Baade PD, Turrell G, Aitken JF. A multilevel study of the determinants of area-level inequalities in colorectal cancer survival. BMC Cancer. 2010;10:24.CrossRefPubMedPubMedCentral
22.
go back to reference Dejardin O, Remontet L, Bouvier A, Danzon A, Tretarre B, Delafosse P, Molinié F, Maarouf N, Velten M, Sauleau E. Socioeconomic and geographic determinants of survival of patients with digestive cancer in France. Br J Cancer. 2006;95:944–9.CrossRefPubMedPubMedCentral Dejardin O, Remontet L, Bouvier A, Danzon A, Tretarre B, Delafosse P, Molinié F, Maarouf N, Velten M, Sauleau E. Socioeconomic and geographic determinants of survival of patients with digestive cancer in France. Br J Cancer. 2006;95:944–9.CrossRefPubMedPubMedCentral
23.
go back to reference Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. In: Kogenivas MPN, Susser M, Boffetta P, editors. Social inequalities and cancer. Lyon: IARC Scientific Publications; 1997. p. 377–97. Auvinen A, Karjalainen S. Possible explanations for social class differences in cancer patient survival. In: Kogenivas MPN, Susser M, Boffetta P, editors. Social inequalities and cancer. Lyon: IARC Scientific Publications; 1997. p. 377–97.
24.
go back to reference Baade PD, Fritschi L, Eakin EG. Non-cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control. 2006;17:287–97.CrossRefPubMed Baade PD, Fritschi L, Eakin EG. Non-cancer mortality among people diagnosed with cancer (Australia). Cancer Causes Control. 2006;17:287–97.CrossRefPubMed
25.
go back to reference Australian Institute of Health and Welfare & Cancer Australia. Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Canberra: AIHW; 2012. Australian Institute of Health and Welfare & Cancer Australia. Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Canberra: AIHW; 2012.
26.
go back to reference Charvat H, Bossard N, Daubisse L, Binder F, Belot A, Remontet L. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers. Cancer Epidemiol. 2013;37:857–63.CrossRefPubMed Charvat H, Bossard N, Daubisse L, Binder F, Belot A, Remontet L. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers. Cancer Epidemiol. 2013;37:857–63.CrossRefPubMed
Metadata
Title
Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks
Authors
Vincent Y. F. He
John R. Condon
Peter D. Baade
Xiaohua Zhang
Yuejen Zhao
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Population Health Metrics / Issue 1/2017
Electronic ISSN: 1478-7954
DOI
https://doi.org/10.1186/s12963-016-0118-9

Other articles of this Issue 1/2017

Population Health Metrics 1/2017 Go to the issue